TRANQUIS THERAPEUTICS
Tranquis Therapeutics is discovering and developing innovative medicines with the potential to revolutionize the management of neurodegenerative and aging-related diseases and to dramatically reduce the burden these illnesses place on patients, families and societies worldwide. Founded on groundbreaking neuro-immunology research from the laboratory of Professor Edgar Engleman, MD, at Stanford University, Tranquis’ novel therapeutic approach targets underlying myeloid immune cell dysfunction th... at has been linked to a variety of nervous system disorders. The company’s portfolio is comprised of small molecules which cross the blood-brain barrier, and the lead therapeutic candidate has demonstrated highly encouraging effects in challenging preclinical models of Amyotrophic Lateral Sclerosis (ALS), Frontotemporal Dementia (FTD), Parkinson’s Disease (PD), and age-related cognitive impairment. Tranquis plans to initiate development in orphan neurodegenerative diseases such as ALS and FTD and later expand into more prevalent diseases such as PD and Alzheimer’s Disease.
TRANQUIS THERAPEUTICS
Industry:
Biotechnology Life Science
Founded:
2016-01-01
Address:
San Mateo, California, United States
Country:
United States
Website Url:
http://www.tranquis.com
Total Employee:
1+
Status:
Active
Contact:
(650) 684-8950
Email Addresses:
[email protected]
Total Funding:
30 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Similar Organizations
Atalanta Therapeutics
Atalanta Therapeutics is a biotechnology company pioneering new treatment options for neurodegenerative diseases.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Voyager Therapeutics
Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system
Current Advisors List
Current Employees Featured
Founder
Investors List
Correlation Ventures
Correlation Ventures investment in Series A - Tranquis Therapeutics
Vivo Capital
Vivo Capital investment in Series A - Tranquis Therapeutics
Remiges Ventures
Remiges Ventures investment in Series A - Tranquis Therapeutics
SR One
SR One investment in Series A - Tranquis Therapeutics
Hillsborough Venture
Hillsborough Venture investment in Series A - Tranquis Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2021-12-01 | Tranquis Therapeutics Strengthens Leadership Team with Additions of Janet Hurt, MPH, as SVP of Clinical Evidence Generation and Faisal Shawwa, MBA, as SVP of Finance |
Official Site Inspections
http://www.tranquis.com Semrush global rank: 6.89 M Semrush visits lastest month: 711
- Host name: 210.252.154.104.bc.googleusercontent.com
- IP address: 104.154.252.210
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
